FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Blenheim Pharmacal Clarithromycin Tablets Recall

Clarithromycin Tablets, USP, 500 mg, 20 Tablets, Rx Only, Dist

Blenheim Pharmacal, Inc. · North Blenheim, NY

Risk level
Class II
Reported by FDA
Jun 3, 2015
Recall ID
D-1110-2015
Check your lot numberHow we source this data

Summary

Blenheim Pharmacal recalled Clarithromycin Tablets starting May 22, 2015. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-1110-2015 on Jun 3, 2015. Reason: cGMP Deviations; products being recalled in response to a recall notice from the manufacturer, Wockhardt Limited, following a FDA inspection which noted inadequate investigation of market complaints, resulting in unsuccessful identification of root causes, and the investigation not being expanded to prevent repeat failure. Status: Terminated.

Why it was recalled

cGMP Deviations; products being recalled in response to a recall notice from the manufacturer, Wockhardt Limited, following a FDA inspection which noted inadequate investigation of market complaints, resulting in unsuccessful identification of root causes, and the investigation not being expanded to prevent repeat failure

Product description

Clarithromycin Tablets, USP, 500 mg, 20 Tablets, Rx Only, Dist. By: Wockhardt USA LLC, Parsippany, NJ 07054, Repackaged By: Blenheim Pharmacal Inc. North Blenheim, NY 12131, NDC 10544-522-20, MFG: 64679-904-02

Lot numbers, UPCs & expiration codes

Lot BP18181301, Exp. Date 02/29/2016

Where it was sold

Indiana

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1110-2015
Classification
Class II
Status
Terminated
Recall initiated
May 22, 2015
FDA report date
Jun 3, 2015
Quantity
50 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Blenheim Pharmacal, Inc.

Original FDA data

Every field from FDA enforcement report D-1110-2015, exactly as published.

Show all FDA fields
City
North Blenheim
State
NY
Status
Terminated
Country
United States
Event ID
71331
Address
119 Creamery Road
Code information
Lot BP18181301, Exp. Date 02/29/2016
Postal code
12131
Report date
Jun 3, 2015
Product type
Drugs
Recall number
D-1110-2015
Classification
Class II
Recalling firm
Blenheim Pharmacal, Inc.
Product quantity
50 bottles
Termination date
Jan 15, 2016
Reason for recall
cGMP Deviations; products being recalled in response to a recall notice from the manufacturer, Wockhardt Limited, following a FDA inspection which noted inadequate investigation of market complaints, resulting in unsuccessful identification of root causes, and the investigation not being expanded to prevent repeat failure
Voluntary / mandated
Voluntary: Firm initiated
Product description
Clarithromycin Tablets, USP, 500 mg, 20 Tablets, Rx Only, Dist. By: Wockhardt USA LLC, Parsippany, NJ 07054, Repackaged By: Blenheim Pharmacal Inc. North Blenheim, NY 12131, NDC 10544-522-20, MFG: 64679-904-02
Distribution pattern
Indiana
Recall initiation date
May 22, 2015
Initial firm notification
Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
Center classification date
May 28, 2015

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1110-2015, published Jun 3, 2015. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls